In the DM group, the ratio of patients using oral hypoglycemic agent, insulin, both oral hypoglycemic agent and insulin, and no drug for treatment were 50 % (n = 33), 21.2 % (n = 14), 9.1 % (n = 6), and 19.7 % (n = 13). This evidence concerns the gene INS and diabetes mellitus.